Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 163.5
-1.39 %
$ 8.36 B
Market Cap
20.39
P/E
Price Target
Average
44.75%
Revenue Forecast
Estimate
5.99%
EBIT
Estimate
10.63%
Net Income
Estimate
17.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Charles River Laboratories International, Inc.
Wall Street analysts predict an average 1-year price target for CRL of $237 , with forecasts ranging from
a
low of
$151 to a high of $300 .
CRL Lowest Price Target
Wall Street Target
151 USD
-7.65%
CRL Average Price Target
Wall Street Target
237 USD
44.75%
CRL Highest Price Target
Wall Street Target
300 USD
83.49%
REVENUE FORECAST
Revenue Forecast Chart CRL
EBIT FORECAST
EBIT Forecast Chart CRL
NET INCOME FORECAST
Net Income Chart CRL